| Literature DB >> 28947447 |
Sang Cheol Seong1, Yeon-Yong Kim2, Sue K Park3,4,5, Young Ho Khang6,7, Hyeon Chang Kim8, Jong Heon Park2, Hee-Jin Kang2, Cheol-Ho Do2, Jong-Sun Song2, Eun-Joo Lee2, Seongjun Ha2, Soon Ae Shin9, Seung-Lyeal Jeong2.
Abstract
PURPOSE: The National Health Insurance Service-Health Screening Cohort (NHIS-HEALS) is a cohort of participants who participated in health screening programmes provided by the NHIS in the Republic of Korea. The NHIS constructed the NHIS-HEALS cohort database in 2015. The purpose of this cohort is to offer relevant and useful data for health researchers, especially in the field of non-communicable diseases and health risk factors, and policy-maker. PARTICIPANTS: To construct the NHIS-HEALS database, a sample cohort was first selected from the 2002 and 2003 health screening participants, who were aged between 40 and 79 in 2002 and followed up through 2013. This cohort included 514 866 health screening participants who comprised a random selection of 10% of all health screening participants in 2002 and 2003. FINDINGS TO DATE: The age-standardised prevalence of anaemia, diabetes mellitus, hypertension, obesity, hypercholesterolaemia and abnormal urine protein were 9.8%, 8.2%, 35.6%, 2.7%, 14.2% and 2.0%, respectively. The age-standardised mortality rate for the first 2 years (through 2004) was 442.0 per 100 000 person-years, while the rate for 10 years (through 2012) was 865.9 per 100 000 person-years. The most common cause of death was malignant neoplasm in both sexes (364.1 per 100 000 person-years for men, 128.3 per 100 000 person-years for women). FUTURE PLANS: This database can be used to study the risk factors of non-communicable diseases and dental health problems, which are important health issues that have not yet been fully investigated. The cohort will be maintained and continuously updated by the NHIS. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: Cohort Studies; National Health Programs; administrative claims; risk factors
Mesh:
Year: 2017 PMID: 28947447 PMCID: PMC5623538 DOI: 10.1136/bmjopen-2017-016640
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
General characteristics of the National Health Insurance Service-Health Screening Cohort subjects at baseline (2002–2003)
| Variables | n | % | |
| Sex | Men | 279 125 | 54.2 |
| Women | 235 741 | 45.8 | |
| Age | 40–44 | 129 979 | 25.2 |
| Mean: 52.641 | 45–49 | 107 002 | 20.8 |
| SD: 9.635 | 50–54 | 80 080 | 15.6 |
| 55–59 | 64 952 | 12.6 | |
| 60–64 | 59 328 | 11.5 | |
| 65–69 | 41 828 | 8.1 | |
| 70–74 | 21 615 | 4.2 | |
| 75–79 | 10 082 | 2.0 | |
| Region | Seoul metropolitan city | 89 344 | 17.4 |
| Other metropolitan cities | 141 055 | 27.4 | |
| Non-metropolitan area | 284 467 | 55.3 | |
| Insurance type | Self-employed insured | 197 992 | 38.5 |
| Employed insured | 316 359 | 61.4 | |
| Medical aid beneficiary | 515 | 0.0 | |
| Disability | No | 511 964 | 99.4 |
| Yes | 2902 | 0.6 | |
| No of participants (biennial) in 2002–2013 | 2002–2003 | 514 866 | 100.0 |
| 2004–2005 | 334 966 | 65.1 | |
| 2006–2007 | 352 158 | 68.4 | |
| 2008–2009 | 361 043 | 70.1 | |
| 2010–2011 | 364 757 | 70.9 | |
| 2012–2013 | 345 693 | 67.1 | |
| The frequency of biennial screening participation in 2002–2013 | 6 | 162 782 | 31.6 |
| 5 | 129 786 | 25.2 | |
| 4 | 88 755 | 17.2 | |
| 3 | 58 628 | 11.4 | |
| 2 | 42 042 | 8.2 | |
| 1 | 32 873 | 6.4 | |
| Cigarette smoking | Non-smoker | 112 577/218 147 | 42.3/96.2 |
| Ex-smoker | 41 519/2170 | 15.6/1.0 | |
| Current smoker | 112 143/6476 | 42.1/2.9 | |
| Smoking duration | <10 years | 18 724/3108 | 12.2/36.0 |
| 10–29 years | 93 620/3646 | 60.9/42.2 | |
| ≥30 years | 41 318/1892 | 26.9/21.9 | |
| Alcohol drinking | Rarely | 96 441/189 721 | 35.1/82.5 |
| 2–3 times per month | 52 995/24 104 | 19.3/10.5 | |
| More than once per week | 125 688/16 134 | 45.7/7.0 | |
| Exercise | None | 134 524/153 342 | 49.7/67.0 |
| 1–2 times per week | 80 104/37 738 | 29.6/16.5 | |
| More than three times per week | 55 916/37 669 | 20.7/16.5 | |
Major variables in the National Health Insurance Service-National Health Screening Cohort database
| Domain | Variables | Year | ||||||||||||
| 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | |||
| Target health problems | Hypertension | Systolic blood pressure | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| Diastolic blood pressure | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
| Diabetes mellitus | Fasting blood glucose | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Dyslipidaemia | Total cholesterol | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Triglyceride | √ | √ | √ | √ | √ | |||||||||
| HDL (high densitiy lipoprotein) cholesterol | √ | √ | √ | √ | √ | |||||||||
| LDL (low density lipoprotein) cholesterol | √ | √ | √ | √ | √ | |||||||||
| Anaemia | Haemoglobin | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Kidney/urinary disease | Urine glucose | √ | √ | √ | √ | √ | √ | √ | ||||||
| Urine blood | √ | √ | √ | √ | √ | √ | √ | |||||||
| Urine pH | √ | √ | √ | √ | √ | √ | √ | |||||||
| Urine protein | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
| Chronic kidney disease | Creatinine | √ | √ | √ | √ | √ | ||||||||
| Liver disease | AST (aspartate transaminase)[SGOT (serum glutamic-oxaloacetic transaminase)] | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| ALT (alanine transaminase)[SGPT (serum glutamic-pyruvic transaminase)} | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
| r-GTP (gamma-glutamyl transpeptidase) | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
| Frailty/lower leg weakness | Neurological examination for lower leg for subjects at age 40 or 66 | √ | √ | √ | √ | √ | √ | √ | ||||||
| Osteoporosis | Bone density for subjects at age 40 or 66 | √ | √ | √ | √ | √ | √ | √ | ||||||
| Periodontal diseases | Dental examination | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Cognitive impairment, depression | Mental health screening | √ | √ | √ | √ | √ | √ | √ | ||||||
| Common and uncommon diseases | Disease diagnosis per ICD-10 codes; Operation and procedure history, Medication history (generic name code, dose, duration of prescription, and material codes) | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| All-cause and cause- specific deaths | Vital statistics including dates and causes of deaths | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Risk factors | Cigarette smoking | Cigarette smoking status | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| Daily smoking dose | √ | √ | √ | √ | √ | √ | √ | |||||||
| Past daily smoking dose | √ | √ | √ | √ | √ | |||||||||
| Current daily smoking dose | √ | √ | √ | √ | √ | |||||||||
| Smoking duration | √ | √ | √ | √ | √ | √ | √ | |||||||
| Smoking duration (ex-smoker) | √ | √ | √ | √ | √ | |||||||||
| Smoking duration (current smoker) | √ | √ | √ | √ | √ | |||||||||
| Alcohol | Drinking frequency | √ | √ | √ | √ | √ | √ | √ | ||||||
| Days of drinking per week | √ | √ | √ | √ | √ | |||||||||
| Amount of drinking per count | √ | √ | √ | √ | √ | √ | √ | |||||||
| Amount of drinking per day | √ | √ | √ | √ | √ | |||||||||
| Obesity | Body mass index | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Waist circumference | √ | √ | √ | √ | √ | √ | ||||||||
| Physical activity | Days of activity per week | √ | √ | √ | √ | √ | √ | √ | ||||||
| Days of vigorous activity per week | √ | √ | √ | √ | √ | |||||||||
| Days of moderate activity per week | √ | √ | √ | √ | √ | |||||||||
| Days of mild activity per week | √ | √ | √ | √ | √ | |||||||||
| Dental caries, etc | Dental examination | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Medical history and family history | Medical history | Hypertension, diabetes mellitus, dyslipidaemia, pulmonary tuberculosis, stroke, ischaemic heart disease, etc | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
| Family history | Hypertension, diabetes mellitus, stroke, ischaemic heart disease etc | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Healthcare usage | Date of visit, types of medical institutions (clinics/hospitals/tertiary hospitals/public health centres), types of visit (inpatient/outpatient/emergency/intensive care), length of stay, medical cost (insurer/patient) | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Healthcare provider | Location, type of hospitals, no of beds, medical equipment, human resources, specialties of physicians | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
| Socioeconomic and demographic factors | Age, sex, age, residential area, insurance type (the employee insured, the self-employed insured, dependents, medical aid), monthly insurance contributions (a proxy for income), types and grades of disabilities | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | |
Crude and age-standardised (with the 2005 Korean census and world standard populations as references) prevalence rates (%) for specific health problems in the health screening database of the National Health Insurance Service-National Health Screening Cohort database at baseline, 2002–2003
| All | Men | Women | ||||||||||
| Cohort n | Crude rates | Age-standardised rates | Cohort n | Crude rates | Age-standardised rates | Cohort n | Crude rates | Age-standardised rates | ||||
| Census | WHO | Census | WHO | Census | WHO | |||||||
| Anaemia* | 514 256 | 9.2 | 9.8 | 9.8 | 278 866 | 4.4 | 5.6 | 5.9 | 235 390 | 15.6 | 15.9 | 15.5 |
| Diabetes mellitus | 514 190 | 7.9 | 8.2 | 8.4 | 278 826 | 9.0 | 9.4 | 9.6 | 235 364 | 6.2 | 6.4 | 6.6 |
| Prediabetes† | 23.9 | 23.8 | 23.9 | 26.0 | 25.9 | 25.9 | 20.8 | 20.7 | 20.9 | |||
| Hypertension | 514 581 | 34.4 | 35.6 | 36.1 | 278 989 | 38.0 | 39.1 | 39.4 | 235 592 | 29.8 | 30.3 | 31.0 |
| High-normal‡ | 17.0 | 16.9 | 16.8 | 17.8 | 17.8 | 17.8 | 15.7 | 15.5 | 15.6 | |||
| Abnormal liver function test§ | 514 286 | 6.2 | 5.8 | 5.8 | 278 866 | 5.7 | 5.3 | 5.1 | 235 420 | 6.5 | 6.3 | 6.4 |
| Obesity | 514 350 | 2.9 | 2.7 | 2.7 | 278 901 | 2.1 | 1.9 | 1.9 | 235 449 | 3.7 | 3.6 | 3.6 |
| Overweight¶ | 32.1 | 31.2 | 31.0 | 33.1 | 31.4 | 31.0 | 30.6 | 29.8 | 30.1 | |||
| Hypercholesterolaemia** | 513 887 | 14.3 | 14.2 | 14.3 | 278 681 | 13.0 | 12.5 | 12.4 | 235 206 | 15.8 | 15.6 | 16.0 |
| Abnormal urine blood†† | 513 046 | 5.9 | 6.0 | 6.1 | 278 228 | 3.2 | 3.4 | 3.4 | 234 818 | 9.3 | 9.3 | 9.4 |
| Abnormal urine protein‡‡ | 513 095 | 2.0 | 2.0 | 2.0 | 278 252 | 1.9 | 2.0 | 2.0 | 234 843 | 1.9 | 2.0 | 2.0 |
*Hb <13 g/dL (men), <12 g/dL (women).
†Diabetes mellitus: fasting glucose of 126 mg/dL; prediabetes, 100–126 mg/dL.
‡Hypertension: systolic blood pressure of 140 mm Hg or diastolic blood pressure of 90 mm Hg; high-normal, systolic blood pressure of 130 mm Hg or diastolic blood pressure of 85 mm Hg.
§More than two times than upper limit of normal (ULN); ULN for alanine aminotransferase: men, 30 IU/L; women, 19 IU/L.
¶Obesity: body mass index ≥30 kg/m2; overweight: body mass index 25–29.9 kg/m2.
**Total cholesterol ≥240 mg/dL (6.2 mmol/L).
††Urine dip-stick test for occult blood: +1, +2, +3, +4.
‡‡Urine dip-stick test for protein: +1, +2, +3, +4.
Crude and age-standardised (with the 2005 Korean census and world standard populations as references) incidence density (per 100 person-years) for specific health problems in the health screening database of the National Health Insurance Service-National Health Screening Cohort database, 2005–2013
| All | Men | Women | ||||||||||
| Cohort n | Crude rates | Age-standardised rates | Cohort n | Crude rates | Age-standardised rates | Cohort n | Crude rates | Age-standardised rates | ||||
| Census | WHO | Census | WHO | Census | WHO | |||||||
| Incidence density (2005–2013) | ||||||||||||
| Anaemia* | 450 207 | 2.6 | 2.9 | 2.9 | 259 787 | 1.9 | 2.3 | 2.4 | 190 420 | 3.7 | 3.8 | 3.8 |
| Diabetes mellitus† | 461 760 | 1.7 | 1.7 | 1.7 | 243 937 | 2.1 | 2.1 | 2.1 | 217 823 | 1.2 | 1.3 | 1.3 |
| Hypertension‡ | 299 857 | 4.1 | 4.6 | 4.7 | 146 050 | 4.4 | 4.8 | 4.9 | 153 807 | 3.8 | 4.4 | 4.5 |
| Abnormal liver function test§ | 471 917 | 1.4 | 1.4 | 1.3 | 255 924 | 1.1 | 1.0 | 1.0 | 215 993 | 1.8 | 1.8 | 1.8 |
| Obesity¶ | 496 720 | 0.3 | 0.3 | 0.3 | 270 970 | 0.2 | 0.2 | 0.2 | 225 750 | 0.3 | 0.3 | 0.3 |
| Hypercholesterolaemia ** | 420 838 | 2.7 | 2.6 | 2.6 | 230 116 | 2.0 | 1.9 | 1.9 | 190 722 | 3.4 | 3.4 | 3.4 |
| Abnormal urine blood †† | 471 226 | 2.4 | 2.3 | 2.3 | 264 380 | 1.4 | 1.4 | 1.4 | 206 846 | 3.7 | 3.6 | 3.6 |
| Abnormal urine protein‡‡ | 499 428 | 0.7 | 0.7 | 0.8 | 269 992 | 0.8 | 0.8 | 0.8 | 229 436 | 0.7 | 0.7 | 0.7 |
Incident cases were defined as those cases newly diagnosed in 2005–2013 who did not meet the diagnostic criteria in 2002–2004.
*Hb <13 g/dL (men), <12 g/dL (women).
†Fasting glucose of 126 mg/dL.
‡Systolic blood pressure of 140 mm Hg or diastolic blood pressure 90 mm Hg.
§More than two times than upper limit of normal (ULN); ULN for alanine aminotransferase: men, 30 IU/L; women, 19 IU/L.
¶Body mass index ≥30 kg/m2.
**Total cholesterol ≥240 mg/dL (6.2 mmol/L).
††Urine dip-stick test for occult blood: +1, +2, +3, +4.
‡‡Urine dip-stick test for protein: +1, +2, +3, +4.
Number of all-cause deaths through 2012 (10 years after baseline) and crude and age-standardised (with the 2005 Korean census and world standard populations as references) mortality rates (per 100 000 person-years) in the National Health Insurance Service-National Health Screening Cohort database
| All-cause | No of cohort population* | All | Men | Women | |||||||||
| No of deaths | Crude | Age-standardised mortality rates | No of deaths | Crude rate | Age-standardised mortality rates | No of deaths | Crude rate | Age-standardised mortality rates | |||||
| Census | WHO | Census | WHO | Census | WHO | ||||||||
| Mortality rates (2003–2012)† | |||||||||||||
| 2 year (2004) | 512 802 | 3705 | 360.2 | 442.0 | 463.6 | 2748 | 493.1 | 648.9 | 680.4 | 957 | 203.1 | 238.3 | 250.8 |
| 5 year (2007) | 503 007 | 13 097 | 513.0 | 646.0 | 678.3 | 9 336 | 676.5 | 917.8 | 963.0 | 3761 | 320.6 | 383.9 | 404.8 |
| 10 year (2012) | 483 421 | 33 058 | 657.9 | 865.9 | 910.2 | 22 684 | 839.0 | 1199.9 | 1260.5 | 10 374 | 447.0 | 556.2 | 586.4 |
*No of cohort population at the end of the year.
†Death cases were defined as those cases who died in 2003–2012.
Figure 1Survival curve of participants by sex in the National Health Insurance Service-National Health Screening Cohort database.
Cause-specific death rates for leading causes of death (2003–2013) and age-standardised (with the 2005 Korean census and world standard populations as references) mortality rates (per 100 000 person-years) in the National Health Insurance Service-National Health Screening Cohort database
| Rank | All | Men | Women | |||||||||
| Cause of death | Crude rates | Age-standardised rates | Cause of death | Crude rates | Age-standardised rates | Cause of death | Crude rates | Age-standardised rates | ||||
| Census | WHO | Census | WHO | Census | WHO | |||||||
| 1 | Malignant neoplasms | 269.5 | 239.5 | 264.4 | Malignant neoplasms | 365.8 | 364.1 | 406.6 | Malignant neoplasms | 157.6 | 128.3 | 140.5 |
| 2 | Cerebrovascular diseases | 68.8 | 66.9 | 76.5 | Heart diseases | 71.7 | 79.2 | 91.0 | Cerebrovascular diseases | 63.5 | 55.4 | 64.5 |
| 3 | Heart diseases | 59.7 | 60.8 | 70.8 | Cerebrovascular diseases | 73.3 | 78.9 | 89.0 | Heart diseases | 45.7 | 42.0 | 50.8 |
| 4 | Suicide | 32.1 | 30.0 | 31.6 | Suicide | 44.3 | 43.3 | 45.6 | Diabetes mellitus | 22.8 | 20.0 | 23.5 |
| 5 | Diabetes mellitus | 25.6 | 24.5 | 28.1 | Chronic lower respiratory infections | 26.8 | 32.2 | 38.1 | Suicide | 18.0 | 15.8 | 16.9 |
| 6 | Transport accidents | 23.8 | 21.6 | 22.6 | Transport accidents | 33.2 | 31.3 | 32.6 | Transport accidents | 12.8 | 11.2 | 12.0 |
| 7 | Chronic lower respiratory infections | 19.0 | 19.8 | 23.7 | Pneumonia | 19.7 | 30.8 | 39.7 | Pneumonia | 9.8 | 11.1 | 14.5 |
| 8 | Pneumonia | 15.1 | 19.5 | 25.1 | Diabetes mellitus | 28.1 | 28.9 | 32.3 | Hypertensive diseases | 11.2 | 9.9 | 11.8 |
| 9 | Diseases of liver | 18.0 | 15.6 | 16.3 | Diseases of liver | 28.2 | 25.1 | 26.0 | Chronic lower respiratory infections | 10.0 | 9.8 | 12.3 |
| 10 | Hypertensive diseases | 10.0 | 11.0 | 13.5 | Hypertensive diseases | 8.9 | 12.5 | 15.8 | Alzheimer’s disease | 4.6 | 7.0 | 9.9 |
The cause of death was classified using the selection list of 56 causes of death provided by Statistics Korea, which originated from the list of 80 causes of death for the tabulation of mortality statistics recommended by WHO.
Figure 2The major 10 causes of death by sex in the cohort sample of the National Health Insurance Service-National Health Screening Cohort database.